An Open-Label, Multicenter, Phase 1b/2 Study Of The Safety And Efficacy Of TL-895 Combined With KRT-232 In Subjects With Relapsed/Refractory (R/R) FLT3+ Acute Myeloid Leukemia (AML) Read more
Vyxeos Outpatient Induction Therapy Without Subsequent Planned Admission: A Multicenter Analysis Of Safety And Medical Resource Utilization Read more
Phase IB/II Of CPX-351 As Maintenance Therapy In AML Patients Ineligible For Bone Marrow Transplantation Read more
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study To Assess The Efficacy And Safety Of Entospletinib In Combination With Intensive Induction And Consolidation Chemotherapy In Adults With Actively Diagnosed Nucleophosmin 1-Mutated (NPM1) Acute Myeloid Leukemia Read more
Prospective Multicenter Observational Study Of Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma Starting Second- Or Third-Line Therapy And Not Receiving Autologous Stem Cell Transplant (REAL-MIND) Read more
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of dociparstat sodium in combination with standard chemotherapy for the treatment of ACTIVEly-diagnosed acute myeloid leukemia Read more
Phase 3 Study To Evaluate The Safety And Efficacy Of Magrolimab In Combination With Azacitidine Versus Physician’s Choice Of Venetoclax In Combination With Azacitidine Or Intensive Chemotherapy In Previously Untreated Adults With TP53 Mutant Acute Myeloid Leukemia (ENHANCE-2) Read more
